scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Concord Biotech Ltd

Feedback
Concord Biotech Ltd

Concord Biotech Ltd (CONCORDBIO) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 202,243
Feb 28, 2025 15:58 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹1,496.10
₹-93.20 (-5.86%)
₹1480.05 Low
Today’s Performance
₹1577.05 High
₹1327.05 Low
52 Week’s Performance
₹2664 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -5.86%
  • 1 Week -9.34%
  • 1 Month -26.78%
  • 3 Months -26.43%
  • 6 Months -7.22%
  • 1 Year 1.67%
  • 3 Years 0.00%
  • 5 Years 0.00%

Company Stories

Jhunjhunwala loses Rs 1,600 cr in just 2 sessions as this stock tanks 30% Concord Biotech shares: The value of Jhunjhunwala's stake crumbled about Rs 1,590.42 crore to Rs 3,730.90 on Monday from Rs 5,321.32 crore on Thursday. `As per the latest shareholding pattern, Jhunjhunwala owned 2,51,99,240 equity shares, or 24.09 per cent stake in the company as of December 31, 2024.

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta 0.82
  • 52-Week Low (₹) 1,327.05
  • 52-Week High (₹) 2,664.00
  • Price-to-Book (X)* 9.84
  • Dividend Yield (%) 0.59
  • Price-to-Earnings (P/E) (X)* 47.94
  • Earnings Per Share (₹) 31.19
  • Sector Price Earning (X)* 31.64
  • Market Cap (₹ Cr.)* 15,651.63
  • * Vaues as of last close price

COMPETITORS

BT TV

India’s Q3 GDP at 6.2%| What It Means for 'BHARAT' 2:25 India’s Q3 GDP at 6.2%| What It Means for 'BHARAT'
GDP AT 6.2%: WHAT’S NEXT? 1:48 Will India’s GDP Growth Accelerate Beyond 7% This Year? Madan Sabnavis Weighs In
India Q3FY25 GDP Data Explained | Major Highlights & What It Means For You 32:07 India Q3FY25 GDP Data Explained | Major Highlights & What It Means For You
World Bank: India Needs 7.8% Growth To Become High Income Country By 2047 5:40 World Bank: India Needs 7.8% Growth To Become High Income Country By 2047
Sanjay Doshi Of KPMG Tells Us The Effect Of Interest Rate Cuts On The Banking Sector 3:17 Sanjay Doshi Of KPMG Tells Us The Effect Of Interest Rate Cuts On The Banking Sector
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Jan 25, 2024 Sell
BNP PARIBAS ARBITRAGE
  • Qty 153421
  • Average Price ₹1,421.70
Jan 25, 2024 PURCHASE
SOCIETE GENERALE
  • Qty 153421
  • Average Price ₹1,421.70
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Aug 18, 2023 PURCHASE
NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL
  • Qty 899037
  • Average Price ₹900.05
Aug 18, 2023 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 735455
  • Average Price ₹935.17
Aug 18, 2023 PURCHASE
NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 1131896
  • Average Price ₹930.12
Aug 18, 2023 Sell
NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 1131896
  • Average Price ₹930.55
Aug 18, 2023 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 735455
  • Average Price ₹935.55
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Concord Biotech Ltd share price previously?
Concord Biotech Ltd share price was down by -5.86% from the previous closing price of ₹1,589.30.
Who are peers of Concord Biotech Ltd?
The peers of Concord Biotech Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd,
Who is/are the promoter/promoters of Concord Biotech Ltd?
The promotor/promotors of Concord Biotech Ltd are SUDHIR JAIRAM VAID, ANKUR VAID, Ravi Kapoor, Rajiv Agarwal, BHARTI KHANNA, Amitabh Thakore, Arvind Agarwal, Jayaram Easwaran, Mandayam Chakravarthy Sriraman, S Prakash.
What has been 52-week high of Concord Biotech Ltd stocks?
The highest price of Concord Biotech Ltd stock is ₹2,664.00 in the last 52-week.
What is the share price of Concord Biotech Ltd (CONCORDBIO) today on NSE?
As on Feb 28, 2025, Concord Biotech Ltd (CONCORDBIO)’s share price on NSE is Rs 1496.1
What is the market cap of Concord Biotech Ltd (CONCORDBIO?)
The current market capitalisation of Concord Biotech Ltd (CONCORDBIO) is 15,651.63 crores
What is Concord Biotech Ltd Share symbol?
The symbol of Concord Biotech Ltd is CONCORDBIO.
What is the PE ratio of Concord Biotech Ltd (CONCORDBIO)?
The current PE ratio of Concord Biotech Ltd (CONCORDBIO) is 47.94.
What is the PB ratio of Concord Biotech Ltd (CONCORDBIO)?
The current PB ratio of Concord Biotech Ltd (CONCORDBIO) is 9.84.
Today’s High & Low share prices of Concord Biotech Ltd (CONCORDBIO) on NSE?
Today, the share price of Concord Biotech Ltd (CONCORDBIO) on NSE touched a high of Rs 1577.05 and a low of Rs 1480.05
What price did Concord Biotech Ltd (CONCORDBIO) shares open on the NSE today?
On NSE, the share price of Concord Biotech Ltd (CONCORDBIO) opened at Rs 1577.05
What is the 52-week high of Concord Biotech Ltd (CONCORDBIO)?
The 52-week high price of Concord Biotech Ltd (CONCORDBIO) is Rs 2664
What is the 52-week low of Concord Biotech Ltd (CONCORDBIO) ?
The 52-week low price of Concord Biotech Ltd (CONCORDBIO) is Rs 1327.05

ABOUT CONCORD BIOTECH

Concord Biotech Ltd, incorporated in the year 1984, has its registered office in 1482-86 Trasad Road, Dholka, Ahmedabad, Gujarat, 382225, 91-079-68138700. The main industry in which Concord Biotech Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Concord Biotech Ltd is/are Deloitte Haskins & Sells/BSR & Co LLP. In the main management, SUDHIR JAIRAM VAID is chairman and S Prakash is the company secretary for Concord Biotech Ltd.

  • SJV SUDHIR JAIRAM VAID Chairman & Managing Director
  • AV ANKUR VAID Joint Managing Director & CEO
  • RK Ravi Kapoor Non Executive Director
  • RA Rajiv Agarwal Nominee
  • BK BHARTI KHANNA Independent Director
  • AT Amitabh Thakore Independent Director
  • AA Arvind Agarwal Independent Director
  • JE Jayaram Easwaran Independent Director
  • MCS Mandayam Chakravarthy Sriraman Independent Director
  • SP S Prakash Assistant VP (Finance) & CS

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement